Variable | AMT (N = 1,005) | DAPT (N = 1,458) | DAPT ≥ 6 months (N = 770) | p-value |
---|---|---|---|---|
Age (Years) | 65.67 ± 10.02 | 64.71 ± 10.02 | 64.13 ± 9.94 | 0.019 |
Sex (Male, n) | 761 (75.8%) | 1,060 (72.7%) | 526 (68.3%) | 0.086 |
Race/Ethnicity (n) | 0.282 | |||
Caucasian | 885 (88.1%) | 1,255 (86.1%) | 639 (83.0%) | |
African American | 32 (3.2%) | 58 (4.0%) | 42 (5.5%) | |
Native American | 37 (3.7%) | 67 (4.6%) | 40 (5.2%) | |
Hispanic | 25 (2.8%) | 44 (3.0%) | 30 (3.9%) | |
Asian | 13 (1.3%) | 18 (1.2%) | 9 (1.2%) | |
Pacific Islander | 1 (0.1%) | 1 (0.1%) | 0 | |
Multiple | 2 (0.2%) | 9 (0.6%) | 6 (0.8%) | |
Unknown | 10 (1.0%) | 6 (0.4%) | 4 (0.5%) | |
BMI (Kg/m2) | 30.63 ± 5.78 | 30.75 ± 5.98 | 30.83 ± 5.87 | 0.620 |
Smoker (n) | 516 (51.4%) | 816 (56.1%) | 445 (57.8%) | 0.478 |
Co-morbidities (n) | 0.007 | |||
Hypertension | 873 (86.9%) | 1,268 (87.0%) | 670 (87.0%) | 0.941 |
CVA | 70 (7.0%) | 131 (9.0%) | 80 (10.4%) | 0.072 |
COPD | 253 (25.2%) | 393 (27.0%) | 230 (27.2%) | 0.323 |
Hyperlipidemia | 707 (70.3%) | 1,029 (70.6%) | 533 (69.2%) | 0.903 |
Diabetes Mellitus | 423 (42.1%) | 583 (40.0%) | 332 (43.1%) | 0.297 |
CKD | 189 (18.8%) | 205 (14.1%) | 114 (14.8%) | 0.002 |
MI | 287 (28.6%) | 461 (31.6%) | 260 (33.8%) | 0.104 |
Stable Angina | 659 (65.6%) | 884 (60.6%) | 487 (63.2%) | 0.013 |
CHF | 215 (21.4%) | 302 (20.7%) | 169 (21.9%) | 0.684 |
PAD | 106 (10.5%) | 216 (14.8%) | 140 (18.2%) | 0.002 |
HbA1c (%) | 6.63 ± 1.52 | 6.61 ± 1.51 | 6.71 ± 1.57 | 0.773 |
GFR > 60 ml/min/1.73 m² (n) | 705 (70.2%) | 1,052 (72.6%) | 546 (71.2%) | 0.208 |
GFR < 60 ml/min/1.73 m² (Avg) | 42.59 ± 13.80 | 44.98 ± 13.11 | 45.09 ± 12.68 | 0.020 |
Ejection Fraction (%) | 52.29 ± 11.55 | 54.44 ± 11.98 | 52.41 ± 11.96 | < 0.001 |
Previous PCI/Stent (n) | 202 (20.1%) | 357 (24.5%) | 0.011 | |
PCI | 188 (18.7%) | 329 (22.6%) | 0.021 | |
Stent | 107 (10.6%) | 194 (13.3%) | 0.048 |